Innovus Pharma Announces Availability Of Ejectdelay™ For Premature Ejaculation In The United States
2/21/2014 8:47:30 AM
SAN DIEGO, Feb. 21, 2014 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTCBB:INNV) today announced the availability of its over the counter ("OTC") benzocaine-based topical premature ejaculation treatment EjectDelay™ in the United States ("U.S.").
Help employers find you! Check out all the jobs and post your resume.
comments powered by